LIFEVANTAGE CORP Form DEF 14A: Definitive proxy statement
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-09-18: Form DEF 14A; Period of report 2026-11-05; Description DEF 14A; Document lfvn-20260918.htm.
- 2025-09-19: Form DEF 14A; Period of report 2025-09-19; Description DEF 14A; Document lfvn-20250917.htm.
- 2024-09-20: Form DEF 14A; Period of report 2024-09-20; Description DEF 14A; Document lfvnproxystatementfy2025.htm.
- 2022-09-30: Form DEF 14A; Period of report 2022-09-16; Description DEF 14A; Document proxystatementfy2023.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-09-18 | DEF 14A | 2026-11-05 | DEF 14A | lfvn-20260918.htm |
| 2025-09-19 | DEF 14A | 2025-09-19 | DEF 14A | lfvn-20250917.htm |
| 2024-09-20 | DEF 14A | 2024-09-20 | DEF 14A | lfvnproxystatementfy2025.htm |
| 2022-09-30 | DEF 14A | 2022-09-16 | DEF 14A | proxystatementfy2023.htm |
| 2021-09-30 | DEF 14A | 2021-09-17 | DEF 14A | proxystatementfy2022.htm |
| 2020-09-30 | DEF 14A | 2020-09-18 | DEF 14A | proxystatementfy2021.htm |
| 2019-10-18 | DEF 14A | 2019-10-10 | DEF 14A | proxystatementfy2020.htm |
| 2018-09-28 | DEF 14A | 2018-09-28 | DEF 14A | proxystatementfy2019.htm |
| 2017-12-20 | DEF 14A | 2017-12-20 | DEF 14A | proxystatementfy2018.htm |
| 2017-01-04 | DEF 14A | 2017-01-04 | DEF 14A | proxystatementfy2017.htm |
| 2015-09-11 | DEF 14A | 2015-10-15 | DEF 14A | proxystatementfy2016.htm |
| 2015-09-01 | DEF 14A | 2015-10-15 | DEF 14A | proxystatementfy2016.htm |
| 2014-10-06 | DEF 14A | 2014-11-19 | DEF 14A | proxystatementfy2015.htm |
| 2013-09-27 | DEF 14A | 2013-11-13 | PROXY STATEMENT | proxystatement.htm |
| 2012-10-09 | DEF 14A | 2012-11-14 | DEFINITIVE PROXY STATEMENT | d421054ddef14a.htm |
| 2011-11-14 | DEF 14A | 2012-01-10 | DEFINITIVE PROXY STATEMENT | d225514ddef14a.htm |
| 2010-10-04 | DEF 14A | 2010-11-19 | DEF 14A | a57414def14a.htm |
| 2009-10-28 | DEF 14A | 2010-01-15 | DEF 14A | d69792def14a.htm |
| 2008-10-28 | DEF 14A | 2009-01-07 | DEF 14A | d64768def14a.htm |
| 2007-10-30 | DEF 14A | 2007-11-30 | DEFINITIVE PROXY STATEMENT | d50865ddef14a.htm |
| 2006-10-20 | DEF 14A | 2006-11-21 | DEFINITIVE PROXY STATEMENT | d40108ddef14a.htm |
| 2004-06-14 | DEF 14A | 2004-06-14 | Definitive proxy statement | yaakdef14a.txt |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |